Metraipolis › archive › dc_0de346fab4e6
The evolving landscape of enzymatic technologies for precision synthesis of antibody-drug conjugates — Europe PMC PMID:42382976
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42382976
- DOI
- 10.1093/abt/tbag020
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T02:41:14.856Z
- SHA-256 of the archived text
b2ecb2dc5d028e29b6ba9704e3ecb0af0622bbfd70054dd70b152247e9f1c5f6- Stable URL of this page
https://metraipolis.com/documento/dc_0de346fab4e6
How to cite
The evolving landscape of enzymatic technologies for precision synthesis of antibody-drug conjugates — Europe PMC PMID:42382976 — Europe PMC (en), https://europepmc.org/article/MED/42382976 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0de346fab4e6 (Metraipolis archive dc_0de346fab4e6, sha256 b2ecb2dc5d028e29b6ba9704e3ecb0af0622bbfd70054dd70b152247e9f1c5f6)
BibTeX
@misc{dc0de346fab4e6,
title = {The evolving landscape of enzymatic technologies for precision synthesis of antibody-drug conjugates — Europe PMC PMID:42382976},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42382976},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0de346fab4e6; sha256 b2ecb2dc5d028e29b6ba9704e3ecb0af0622bbfd70054dd70b152247e9f1c5f6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382976. Agents can read the archived copy with the MCP tool read_document.